Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 3CNS 2Genitourinary 1

Conditions

Wilms Tumor 6Ovarian Neoplasms 6Neuroblastoma 5Testicular Neoplasms 4Sarcoma 4Prostatic Neoplasms 4Osteosarcoma 4Neuroectodermal Tumors, Primitive, Peripheral 4Medulloblastoma 4Kidney Neoplasms 4Astrocytoma 4Optic Nerve Glioma 3Oligodendroglioma 3Glioma 3Familial ependymoma 3Choroid Plexus Neoplasms 3Central Nervous System Neoplasms 3Testicular Germ Cell Tumor 2Teratoma 2Sarcoma, Ewing 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Ovarian Germ Cell Cancer 2Neoplasms 2Liver Neoplasms 2Carcinoma, Renal Cell 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Pancreatic Neoplasms 1Neuroectodermal Tumors 1

Interventions

Zoledronic Acid 2Vincristine 2Irinotecan 2Gemcitabine 2Etoposide 2Doxorubicin 2Cyclophosphamide 2saracatinib 1robatumumab 1radium Ra 223 dichloride 1liposomal doxorubicin 1cc-486 1Temozolomide 1Taxes 1Standard of Care 1Radiation 1Quality of Life 1Psychology, Positive 1Practice Guidelines as Topic 1Patient Reported Outcome Measures 1Palliative Care 1Paclitaxel 1Observation 1Molecular Diagnostic Techniques 1Methods 1Lomustine 1Injections 1Immunotherapy 1Ifosfamide 1Genetic Testing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bone Neoplasms × Temozolomide × Genitourinary × Clear all
NCT00960063 2018-08-27

A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)

Merck Sharp & Dohme LLC

Phase 1 Terminated
4 enrolled 8 charts
CNSGenitourinarySarcoma

Bone Neoplasms, Carcinoma, Renal Cell, Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡